Salicylhydroxamic acid inhibited the luminol-dependent chemiluminescence of human neutrophils stimulated by phorbol 1 2-myristate 13-acetate or the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (fMet-Leu-Phe). This compound had no inhibitory effect on the kinetics of O2,-generation or 02 uptake during the respiratory burst, but inhibited both the peroxidative activity of purified myeloperoxidase and the chemiluminescence generated by a cell-free myeloperoxidase/H202 system. The concentration of salicylhydroxamic acid necessary for complete inhibition of myeloperoxidase activity was 30-50 /SM (I50 values of 3-5 fSM) compared with the non-specific inhibitor NaN3, which exhibited maximal inhibition at 100-200,M (I50 values of 30-50 /uM). Whereas taurine inhibited the luminol chemiluminescence of an H202/HOCI system by HOC1 scavenging, this compound had little effect on myeloperoxidase/H202-dependent luminol chemiluminescence; in contrast, 10 M-salicylhydroxamic acid did not quench HOCI significantly but greatly diminished myeloperoxidase/H202-dependent luminol chemiluminescence, indicating that its effects on myeloperoxidase chemiluminescence were largely due to peroxidase inhibition rather than non-specific HOCI scavenging. Salicylhydroxamic acid prevented the formation of myeloperoxidase Compound II, but only at low H202 concentrations, suggesting that it may compete for the H202-binding site on the enzyme. These data suggest that salicylhydroxamic acid may be used as a potent inhibitor to delineate the function of myeloperoxidase in neutrophil-mediated inflammatory events.
INTRODUCTION
Myeloperoxidase is a haemoprotein located within the azurophilic granules of granulocytes and constitutes up to 5 % of the total cellular protein of mature neutrophils [1] . A wide range of enzymic activities have been attributed to myeloperoxidase, including peroxidase, catalase, oxidase, superoxide dismutase, DNA-binding, chlorination and bactericidal activities [2] [3] [4] [5] [6] [7] , and thus this protein plays an important role in the 02-dependent processes of phagocytes. During phagocytosis it is discharged into the phagocytic vesicle by the process of degranulation, where it reacts with H202 (and possibly 02--) generated during the respiratory burst to form HOCI and related compounds. The potency of the myeloperoxidase/H202/halide system in bactericidal, fungicidal and tumoricidal activities is well documented, and since it may be actively secreted from neutrophils its extracellular activity may also play an important role as an inflammatory mediator.
In view of the crucial and diverse role played by myeloperoxidase in host protection, the discovery that patients with deficiencies in this enzyme have few, if any, clinical symptoms appears paradoxical [8] [9] [10] [11] [12] [13] . Myeloperoxidase deficiencies are described as 'complete' or 'partial', but the latter is a somewhat arbitrary and imprecise definition since neutrophils with 'partial' deficiencies contain 22-60 % of the normal activity of this enzyme [12, 14] . In view of the fact that this enzyme is present in such high concentrations in normal neutrophils, even neutrophils with a substantial 'partial' deficiency may still contain sufficient amounts of this enzyme for full catalytic activity. Detection of myeloperoxidase deficiencies has been revolutionized in recent years by the introduction of automated flow cytochemistry [12, 14] , but, particularly in cases of 'complete' deficiencies, the extent of the deficiency must be quantified by the measurement of catalytic activity in neutrophil extracts. Indeed, in several reports of 'complete' deficiency the enzymic activity ranged from 5 to 25 % of normal values [10, 12] , although contributions from eosinophil contamination must be critically assessed. However, it is generally accepted that patients with myeloperoxidase deficiencies do not usually suffer from recurrent bacterial infections, although the ability of these neutrophils to kill bacteria such as Staphylococcus aureus and Serratia marcescens in vitro was substantially diminished [9, 14] . These patients do, however, suffer from candidal infections, and a correlation between myeloperoxidase deficiencies and leukaemia, preleukaemia and neoplasms in these patients has been reported by several investigators ( [14] [15] [16] and references cited in ref. [8] ).
Since it has been proposed that the activities of other, myeloperoxidase-independent, bactericidal processes are increased to compensate for the absence of this enzyme in deficiencies [9,1 1] , the precise role of myeloperoxidase in the function of normal neutrophils is far from clear. One of the major problems in assessing the function of this enzyme is that a specific chemical inhibitor does not exist. Many studies have used the general and nonspecific haem inhibitor -NaN3, but this compound also inhibits other enzymes involved in neutrophil oxidative metabolism (such as catalase), quenches 102 and 'OH [17] and its broad toxicity renders it useless for cytotoxicity studies. Although monospecific anti-(myeloperoxidase) serum can inhibit the extracellular activity of this enzyme [18, 19] , the role of myeloperoxidase in normal neutrophil function can only be critically assessed when a more specific neutrophil-permeable myelo-peroxidase inhibitor is available. In the present paper we report that salicylhydroxamic acid, an inhibitor of the alternative, cyanide-insensitive, oxidase of plant mitochondria [20] and some other redox enzymes [21] , appears to fulfil this function.
EXPERIMENTAL Isolation and preparation of neutrophils
Polymorphonuclear leucocytes (neutrophils) were isolated from heparinized venous blood from healthy volunteers by utilizing either a dextran/Ficoll sedimentation procedure [18] or Mono-Poly Resolving Medium (Flow Laboratories) as in ref. [22] . After purification cells were suspended in a medium containing 120 mMNaCl, 4.8 mM-KCI, 1.2 mM-KH2P04, 1.3 mM-CaCI2, 1.2 mM-MgSO4, 25 mM-Hepes buffer, pH 7.4, and 0.1 00 bovine serum albumin. Neutrophils (> 980 purity) were counted with the use of a Fuchs-Rosenthal haemocytometer slide and used within 4 h of preparation.
Analytical methods
Chemiluminescence measurements were made in I ml suspensions containing 10 ,tM-luminol [23] with an LKB Wallac 1250 luminometer. Neutrophil suspensions contained 106 cells/ml, and the chemiluminescence of a myeloperoxidase/H202 system in vitro utilized 10 munits of myeloperoxidase/ml and concentrations of H202 as described in the text. The chemiluminescence studies of an H202/HOCI system were performed essentially as described in ref. [24] with 25#,tM-H202, 16 /tM-NaOCl and 10 ,tM-luminol. 02--generation was measured as the superoxide dismutase-inhibitable reduction of cytochrome c in a 1 ml assay mixture containing 5 x 105 neutrophils and 75 ,iM-cytochrome c [25] by the use of a Perkin-Elmer Lambda 5 spectrophotometer, and 02 uptake was measured on 2ml suspensions (1.5 x 106 cells/ml) by using a Clark-type oxygen electrode (Rank Brothers, Cambridge, U.K.). Human myeloperoxidase was purified from buffy coats as described in ref. [26] and had an A430/A280 ratio of 0.74. Myeloperoxidase secretion from neutrophils in response to treatment with 1 ,tM-fMet-Leu-Phe plus 5 ,tg of cytochalasin B/ml was as described in ref. [27] , and activity was assayed by the guaiacol method [28] . Absorption spectra of purified myeloperoxidase were obtained with a Perkin-Elmer Lambda 5 spectrophotometer.
Chemicals fMet-Leu-Phe, PMA, cytochalasin B, luminol, Hepes, guaiacol and salicylhydroxamic acid were from Sigma Chemical Co. All other chemicals were of the highest purity available.
RESULTS AND DISCUSSION Effect of salicylhydroxamic acid and azide on neutrophil function The effect of increasing NaN3 concentrations on fMet-Leu-Phe-plus-cytochalasin B-stimulated neutrophil chemiluminescence is shown in Fig. l(a) : as the concentration of azide in the suspension was increased, so the chemiluminescence response decreased, with maximal inhibition occurring at 200 /IM and an 150 value (concentration of inhibitor necessary for 500 inhibition) of 38 ,M. A similar concentration-dependent inhibition of fMet-Leu-Phe-plus-cytochalasin B-stimulated neutrophil chemiluminescence by salicylhydroxamic acid was observed (Fig. l b) , but the response was more inhibitorsensitive, with maximal inhibition at 50/tM and an 150 value of 5 ,UM. Similar inhibition profiles of chemiluminescence were observed when neutrophils were stimulated with f Met-Leu-Phe alone or phorbol 1 2-myristate 13-acetate (Fig. 1 b) . Effect of salicylhydroxamic acid on oxidant generation and myeloperoxidase activity Since luminol-dependent chemiluminescence largely measures the activity of the myeloperoxidase/H202 system [23, 29] , the effect of salicylhydroxamic acid observed in Fig. 1 may be due to either (a) inhibition of oxidant generation or alternatively (b) inhibition of myeloperoxidase. These alternatives were therefore tested.
As shown in Fig. 2(a) [NaN3] (PM) Fig. 3 . Effects of salicylhydroxamic acid and azide on myeloperoxidase activity Purified myeloperoxidase (10 munits; *) or myeloperoxidase secreted from neutrophils after stimulation with 1 ,sM-fMetLeu-Phe plus 5 jug of cytochalasin B/ml (0) was incubated in the absence or in the presence of salicylhydroxamic acid (a) or NaN3 (b) for 5 min before the measurement of peroxidase activity by the formation of tetraguaiacol in an assay mixture containing 0.13 mM-H202 and 0.34 mM-guaiacol at pH 7.0. (Fig. 2b) . These findings are consistent with salicylhydroxamic acid acting as an inhibitor of myeloperoxidase, since the activity of this enzyme has been shown to regulate°2-generation in activated neutrophils [18] . The direct effect of salicylhydroxamic acid on myeloperoxidase was therefore investigated, by measuring its effects on the activity of the purified enzyme. Fig. 3 shows that the peroxidative activity of the purified enzyme was completely inhibited
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Inhibition of myeloperoxidase/H202 and H202/HOCI chemiluminescence Fig. 3 clearly shows that salicylhydroxamic acid is a potent inhibitor of the peroxidative activity of myeloperoxidase. Similarly, this compound also inhibited (a) the luminol chemiluminescence of a cell-free myeloperoxidase/H202 system, resulting in over 85 %0 inhibition of the response at a concentration of 1O#/M (Table 1) . However, photon emission by this enzymic system may result from one or two sources, namely (a) a peroxidase-dependent oxidation of luminol or (b) the co-oxidation of luminol by H202 and HOCI [24, 30] . Taurine, a scavenger of HOCI [24] , inhibited H202/ HOCl/luminol chemiluminescence by over 850% at a concentration of 250,M but had little effect at this concentration on luminol chemiluminescence of the myeloperoxidase/H202 system (Table 1 ). In contrast, 10 /tM-salicylhydroxamic acid had little effect on H202/HOCI chemiluminescence (12°/), but inhibited myeloperoxidase/H202 chemiluminescence at this concentration by over 850. Higher concentrations of salicylhydroxamic acid (50 /tM) inhibited H202/HOCI chemiluminescence, which may be attributed to HOCI (rather than H202) scavenging, since it had no effect on catalase activity. These results together strongly suggest that the inhibition ofthe myeloperoxidase/H202/luminol chemiluminescence by salicylhydroxamic acid is due to its effects as a peroxidase inhibitor, and that HOCI is not the major source of photon emission in this system since taurine had little effect. Effect of H202 concentration on inhibition of myeloperoxidase by salicylhydroxamic acid Purified myeloperoxidase was incubated in the presence or in the absence of 10 tM-salicylhydroxamic acid (together with 10 jtM-luminol) and the chemiluminescence response was measured after the additions of various concentrations of H202 (Fig. 4) . At an H202 concentration of 1 /tM the chemiluminescence response was inhibited by over 900, but as the H202 con- Salicylhydroxamic acid has been extensively used as an inhibitor of the alternative, cyanide-insensitive, oxidase of mitochondria of plants and other eukaryotes [20, 33] and has no inhibitory effect on catalase, superoxide dismutase or cytochrome oxidase [21] . It has been previously shown to inhibit horseradish peroxidase [21] and here we now show that it acts as a potent inhibitor of myeloperoxidase. This compound effectively inhibited the activity of the purified enzyme (Fig. 3) and also the chemiluminescence responses generated by myeloperoxidase/H202 both in a cell-free system and in intact cells ( Fig. 1 and Table 1 ). It may also act as a scavenger of HOCI (Table 1) , but, since 10 ,uM-salicylhydroxamic acid did not quench HOCl but substantially inhibited myeloperoxidase/H202 chemiluminescence (in contrast with the effects of the HOCI scavenger taurine), its effects on myeloperoxidase chemiluminescence are largely due to its action as a peroxidase inhibitor rather than as a non-specific HOCl scavenger. It had little effect on the kinetics of 02-generation and 02 uptake, other than a slight enhancement of respiratory-burst activity that would be predicted since myeloperoxidase has been shown to regulate the duration of the respiratory burst [18] . Interestingly, salicylhydroxamic acid can inhibit both the intra-and extra-cellular portions of neutrophil chemiluminescence activated by phorbol 12-myristate 13-acetate and fMet-Leu-Phe [19] 
